Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spinal cord stimulation: a seven-year audit.

S R Sundaraj1, C Johnstone, F Noore

  • 1Pain Management Unit, Nepean Teaching Hospital, Sydney University, Penrith, NSW, Australia. sunderaj@bigpond.net.au

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|April 27, 2005
PubMed
Summary

Spinal cord stimulation (SCS) effectively manages chronic neuropathic pain, with over 74% of patients experiencing significant pain reduction. This treatment also improves daily activities and reduces opioid use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cells transit through a quiescent-like state to convert to neurons at high rates.

bioRxiv : the preprint server for biology·2024
Same author

Reassessing the numbers: discrepancies, implications and potential solutions for the NELA Risk Calculator.

Anaesthesia·2023
Same author

Measurement of the Positive Muon Anomalous Magnetic Moment to 0.46 ppm.

Physical review letters·2021
Same author

Awake tracheal intubation with the ProVu™ video stylet: a case series.

Anaesthesia reports·2021
Same author

Associated risks posed to healthcare workers when intubating the trachea of patients with COVID-19: a reply.

Anaesthesia·2020
Same author

Tracheal intubation of patients with COVID-19: global risks.

Anaesthesia·2020

Area of Science:

  • Neurology
  • Pain Management
  • Neurosurgery

Background:

  • Chronic neuropathic pain presents a significant challenge in pain management.
  • Spinal cord stimulation (SCS) is an established therapy for refractory neuropathic pain.

Purpose of the Study:

  • To assess the efficacy and safety of spinal cord stimulation (SCS) for chronic neuropathic pain.
  • To evaluate outcomes including pain relief, functional improvement, and medication reduction in an Australian cohort.

Main Methods:

  • Retrospective review of 138 patients undergoing SCS trials between 1995 and 2002.
  • Data collected included pain reduction, activities of daily living (ADLs), return to work, and opioid analgesia use.
  • Clinical, psychological, demographic, and financial data were also analyzed.

Related Experiment Videos

Main Results:

  • 74.7% of patients achieved >50% pain reduction and proceeded to permanent SCS implantation.
  • At 1 year post-implantation, 84.4% maintained >50% pain reduction.
  • Significant improvements were observed in ADLs (73.6%) and return to work (24%), with reduced opioid use.

Conclusions:

  • Spinal cord stimulation (SCS) demonstrates effectiveness in controlling chronic neuropathic pain.
  • Optimal outcomes are associated with SCS integrated into multidisciplinary pain management.
  • SCS offers a valuable therapeutic option for patients with chronic neuropathic pain.